BioAtla downgraded to Neutral from Buy at H.C. Wainwright
The Fly

BioAtla downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright analyst Arthur He downgraded BioAtla (BCAB) to Neutral from Buy without a price target The firm is awaiting clarity on the company’s pipeline development path. The firm says that with pipeline decisions pending, it is unable to project the cadence of BioAtla’s revenue at this time.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App